Usfda/Dgci Approved Third Generation Everolimus Tender - 140766409

INDIAN AIR FORCE (IAF) has floated a tender for Usfda/Dgci Approved Third Generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent Assorte, Qty: 2. The project location is Kanpur, Uttar Pradesh, India. The reference number is GEM/2026/B/7488553 and it is closing on 16 May 2026. Suppliers can request Register free of cost to get the complete Tender details and download the document.

Procurement Summary

State: Uttar Pradesh

Summary: Usfda/Dgci Approved Third Generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent Assorte, Qty: 2

Deadline: 16 May 2026

Posting Date: 06 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140766409

Document Ref. No.: GEM/2026/B/7488553

Financier: Self Financed

Purchaser Ownership: Public

Document Fees: Refer Document

Tender Value: Refer Document

EMD: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte
Quantity Required: 2

Start Date: 06-05-2026 2:32 PM

End Date: 16-05-2026 3:00 PM
Tender ID: GEM/2026/B/7488553

Documents

Tender Notice

Bid_Document_9272189.pdf

Download All

Corresponding Contract Award Notice